|4Sep 14, 5:07 PM ET

Katzoff David J 4

4 · Alzamend Neuro, Inc. · Filed Sep 14, 2022

Insider Transaction Report

Form 4
Period: 2022-09-14
Katzoff David J
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-09-14$1.11/sh+10,000$11,09228,000 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT